默沙东92亿美元收购Cidara Therapeutics推动流感预防领域发展

默沙东宣布以每股221.5美元现金收购Cidara Therapeutics，交易总价值约92亿美元，预计2026年第一季度完成。此次收购旨在获得Cidara的长效流感抗体药物，推动流感预防领域发展。

相关股票

相关资讯

诺和诺德(NVO.US)首席执行官：我们拥有充足的Wegovy库存。

智通财经·2025/11/17

诺和诺德(NVO.US)首席执行官：我们拥有充足的Wegovy库存。

诺和诺德首席执行官表示，与白宫的协议旨在降低药品价格，同时扩大医保覆盖范围。

格隆汇·2025/11/17

诺和诺德首席执行官表示，与白宫的协议旨在降低药品价格，同时扩大医保覆盖范围。

诺和诺德首席执行官：与白宫达成的协议旨在降低我们药物的价格同时也旨在扩大医疗保险的覆盖范围。

智通财经·2025/11/17

诺和诺德首席执行官：与白宫达成的协议旨在降低我们药物的价格同时也旨在扩大医疗保险的覆盖范围。

获默沙东(MRK.US)92亿美元收购 Cidara (CDTX.US)股价盘前翻番

智通财经·2025/11/14

获默沙东(MRK.US)92亿美元收购 Cidara (CDTX.US)股价盘前翻番

默沙东以每股221.5美元现金收购Cidara Therapeutics

智通财经网·2025/11/14

默沙东以每股221.5美元现金收购Cidara Therapeutics

Cidara Therapeutics 股价继续上涨，盘前上涨104%，因默克同意以约92亿美元收购该公司

美股速递·2025/11/14

Cidara Therapeutics 股价继续上涨，盘前上涨104%，因默克同意以约92亿美元收购该公司

默克将以92亿美元收购Cidara Therapeutics

MT Newswires Live·2025/11/14

默克将以92亿美元收购Cidara Therapeutics

默沙东拟收购Cidara Therapeutics, Inc.，多元化其投资组合，增添晚期抗病毒药物

美股速递·2025/11/14

默沙东拟收购Cidara Therapeutics, Inc.，多元化其投资组合，增添晚期抗病毒药物

默沙东：根据并购协议，默沙东通过其子公司将收购Cidara的所有流通股

美股速递·2025/11/14

默沙东：根据并购协议，默沙东通过其子公司将收购Cidara的所有流通股

默克药厂将以每股221.50美元现金收购Cidara Therapeutics公司。

智通财经·2025/11/14

默克药厂将以每股221.50美元现金收购Cidara Therapeutics公司。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/economy/e0d7686fa8386219791330d46be969bf"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://community-service.laohu8.com/v1/financial/theme/news\",params:#themeId:\"e0d7686fa8386219791330d46be969bf\",region:\"SGP\",,,undefined,":{"bottom":false,"list":[{"cardType":"NEWS","cardId":"NEWS.2584649590","cardData":[{"id":"2584649590","pubTimestamp":1763373023,"title":"诺和诺德(NVO.US)首席执行官：我们拥有充足的Wegovy库存。","summary":"","media":"智通财经","labels":[],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":false,"publishLive":true}],"position":0},{"cardType":"NEWS","cardId":"NEWS.2584646970","cardData":[{"id":"2584646970","pubTimestamp":1763372086,"title":"诺和诺德首席执行官表示，与白宫的协议旨在降低药品价格，同时扩大医保覆盖范围。","summary":"","media":"格隆汇","labels":[],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":true}],"position":0},{"cardType":"NEWS","cardId":"NEWS.2584904646","cardData":[{"id":"2584904646","pubTimestamp":1763372037,"title":"诺和诺德首席执行官：与白宫达成的协议旨在降低我们药物的价格同时也旨在扩大医疗保险的覆盖范围。","summary":"","media":"智通财经","labels":[],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":false,"publishLive":true}],"position":0},{"cardType":"NEWS","cardId":"NEWS.2583503987","cardData":[{"id":"2583503987","pubTimestamp":1763122227,"title":"获默沙东(MRK.US)92亿美元收购 Cidara (CDTX.US)股价盘前翻番","summary":"","media":"智通财经","labels":[],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":false,"publishLive":true}],"position":0},{"cardType":"NEWS","cardId":"NEWS.1179242353","cardData":[{"id":"1179242353","pubTimestamp":1763121961,"title":"默沙东以每股221.5美元现金收购Cidara Therapeutics","summary":"","media":"智通财经网","labels":["movement"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":true,"news_tag":"movement"}],"position":0},{"cardType":"NEWS","cardId":"NEWS.1163990293","cardData":[{"id":"1163990293","pubTimestamp":1763121511,"title":"Cidara Therapeutics 股价继续上涨，盘前上涨104%，因默克同意以约92亿美元收购该公司","summary":"","media":"美股速递","labels":["corporation","merge"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":true,"news_tag":"corporation,merge"}],"position":0},{"cardType":"NEWS","cardId":"NEWS.2583085945","cardData":[{"id":"2583085945","pubTimestamp":1763120939,"title":"默克将以92亿美元收购Cidara Therapeutics","summary":"","media":"MT Newswires Live","labels":["corporation"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":false,"news_tag":"corporation"}],"position":0},{"cardType":"NEWS","cardId":"NEWS.1132885105","cardData":[{"id":"1132885105","pubTimestamp":1763120836,"title":"默沙东拟收购Cidara Therapeutics, Inc.，多元化其投资组合，增添晚期抗病毒药物","summary":"","media":"美股速递","labels":["corporation","merge"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":true,"news_tag":"corporation,merge"}],"position":0},{"cardType":"NEWS","cardId":"NEWS.1179739827","cardData":[{"id":"1179739827","pubTimestamp":1763120835,"title":"默沙东：根据并购协议，默沙东通过其子公司将收购Cidara的所有流通股","summary":"","media":"美股速递","labels":["corporation","merge"],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":true,"publishLive":true,"news_tag":"corporation,merge"}],"position":0},{"cardType":"NEWS","cardId":"NEWS.2583560508","cardData":[{"id":"2583560508","pubTimestamp":1763120831,"title":"默克药厂将以每股221.50美元现金收购Cidara Therapeutics公司。","summary":"","media":"智通财经","labels":[],"importantFlag":0,"likeCount":0,"liked":false,"publishNews":false,"publishLive":true}],"position":0}],"size":10,"nextStartFrom":"1763120831000_402675"},"@#url:\"https://community-service.laohu8.com/v1/theme/info\",params:#region:\"SGP\",,method:\"POST\",data:#themeId:\"e0d7686fa8386219791330d46be969bf\",,,undefined,":{"themeId":"e0d7686fa8386219791330d46be969bf","name":"默沙东92亿美元收购Cidara Therapeutics推动流感预防领域发展","description":"默沙东宣布以每股221.5美元现金收购Cidara Therapeutics，交易总价值约92亿美元，预计2026年第一季度完成。此次收购旨在获得Cidara的长效流感抗体药物，推动流感预防领域发展。","image":"https://static.tigerbbs.com/1201dcc0482be040348fb8d4f228bb68","type":2,"style":4,"follow":false,"createTime":1763131637866,"userCounts":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":e0d7686fa8386219791330d46be969bf}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowSubscriptionFinancial":false,"subscriberCount":0,"allowFollow":false,"hasReward":false,"rewardScore":0,"rewardValidDate":0,"rewardEnd":false,"symbols":["MRK","CDTX"],"tweetCounts":0,"categoryId":"2929bb7468f5415f853fd96fb35d7c3b","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"默沙东92亿美元收购Cidara Therapeutics推动流感预防领域发展","tweetAmount":0,"imageIsDefault":false,"aiDerivativeIssues":[]}}}